Lupin launches patient support program ‘Humrahi‘ for diabetes management
India has the highest prevalence of diabetes globally, with an estimated 77 million people living with the condition and an expected 134 million cases by 2045
India has the highest prevalence of diabetes globally, with an estimated 77 million people living with the condition and an expected 134 million cases by 2045
Aim is to treat Dyslipidemia by inhibiting PCSK9 with a novel entity
The U.S. FDA has determined that the inspection classification of the facility is Voluntary Action Indicated
The campus in Genome Valley will provide services in discovery chemistry & discovery biology, safety toxicology, bioanalytical services and formulation development to global pharmaceutical companies
Ronco succeeds Dr. Christine Dingivan, who will now serve as a senior advisor to Executive Chairman Sastry Chilukuri
Will continue to own a 7.84 per cent stake in Glenmark Life Sciences with the stake reduction
Approval of this product under the PEPFAR program completes Strides’ qualification to all major markets and donor programs including Global Fund and South Africa
In 2030 over 50% of FDA approvals will involve AI discovered and developed drugs
Amneal’s site in Matoda is one of the company’s 12 pharmaceutical manufacturing facilities
Subscribe To Our Newsletter & Stay Updated